Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Fusion Lumos
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Cell Culture
SUBMITTER: Eric Fischer
LAB HEAD: Eric Fischer
PROVIDER: PXD016185 | Pride | 2020-11-20
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
esf_1728_20181109.raw | Raw | |||
esf_1729_20181109.raw | Raw | |||
esf_1730_20181109.raw | Raw | |||
esf_1731_20181109.raw | Raw | |||
esf_1732.raw | Raw |
Items per page: 1 - 5 of 25 |
Nature 20201118 7836
Effective and sustained inhibition of non-enzymatic oncogenic driver proteins is a major pharmacological challenge. The clinical success of thalidomide analogues demonstrates the therapeutic efficacy of drug-induced degradation of transcription factors and other cancer targets<sup>1-3</sup>, but a substantial subset of proteins are resistant to targeted degradation using existing approaches<sup>4,5</sup>. Here we report an alternative mechanism of targeted protein degradation, in which a small m ...[more]